EUVIMEDEUVIMED entdecken
Leserbrief

Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study

Xiao-Ling Guo, Zi-Yu Zhao, Xue-Fei Guo, Ya-Bei Zuo, Jin-Ao Li, Zi-Yuan Nie, Jin-Hai Ren

Neurological Sciences · 2024

DOI: 10.1007/s10072-024-07348-4 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Neurological Sciences, 2024. Verfasst von Xiao-Ling Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. Hauptthemen laut MEDLINE: Rituximab, Central Nervous System Neoplasms, Lenalidomide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RituximabCentral Nervous System NeoplasmsLenalidomideHumansRetrospective StudiesAgedMaleFemaleAged, 80 and overPyrazinesAntineoplastic Combined Chemotherapy ProtocolsMiddle AgedLymphomaTreatment OutcomePiperidinesPyridines

Substanzen

RituximabLenalidomidePyrazinesorelabrutinibPiperidinesPyridines

Autor:innen und Institutionen

  • Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China.
  • Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. 8503116578@163.com.
  • Department of Hematology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, Hebei, China. jinhai1966@sina.cn.

Zitieren

APA

Guo, X. L., Zhao, Z. Y., Guo, X. F., Zuo, Y. B., Li, J. A., Nie, Z. Y., & Ren, J. H. (2024). Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study. Neurological Sciences. https://doi.org/10.1007/s10072-024-07348-4

Vancouver

Guo XL, Zhao ZY, Guo XF, Zuo YB, Li JA, Nie ZY, et al. Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study. Neurological Sciences. 2024. doi:10.1007/s10072-024-07348-4

BibTeX
@article{Guo2024,
  author = {Guo, Xiao-Ling and Zhao, Zi-Yu and Guo, Xue-Fei and Zuo, Ya-Bei and Li, Jin-Ao and Nie, Zi-Yuan and Ren, Jin-Hai},
  title = {Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study},
  journal = {Neurological Sciences},
  year = {2024},
  doi = {10.1007/s10072-024-07348-4}
}
Kostenlos starten →